Bausch & Lomb, Modulight earn FDA approval for photodynamic laser

Bausch & Lomb and Modulight Corporation, a biomedical laser company, have received approval from the U.S. Food and Drug Administration for its ML6710i photodynamic laser. 

Advertisement

The laser would be used with Bausch & Lomb’s Visudyne, an injectable photosensitizing drug used in photodynamic therapy for patients with subfoveal choroidal neovascularization, or the creation of abnormal choroidal blood vessels, due to age-related macular degeneration. 

The ML6710i laser is transportable and controlled from a mobile app. Its shaping unit can be fit into all common slit lamps for eye examinations. 

It is expected to be available for eye care professionals in 2023.

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

  • The American Board of Ophthalmology has appointed Steven Gedde, MD, as its next CEO.  Dr. Gedde is an ophthalmologist and…

Advertisement

Comments are closed.